This event is intended for clinicians, researchers and healthcare professionals.
Speaker
Thomas Lagace, PhD
Scientist & Director
Lipoprotein Receptor Biology Laboratory, UOHI
Associate Professor
Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa
Topic
The evolving story of PCSK9, a secreted protein with roles in cholesterol homeostasis and innate immunity.
PCSK9 promotes degradation of liver LDL receptors, raising blood LDL-cholesterol and related cardiovascular risk. Therapeutic PCSK9 inhibition has revealed an unanticipated role in inflammation and innate immunity.
Location
Centre Auditorium H-2367 and virtually (Zoom).
Cost
Free.
Registration
Required.